Search Results - yanmei+hu

2 Results Sort By:
PLpro Inhibitors Against SARS-CoV-2
There are two cysteine proteases that are encoded by SARS-CoV-2, the main protease (Mpro) and the papain-like protease (PLpro). Both of these proteases have been shown to be essential in viral replication and are validated antiviral drug targets. PLpro cleaves the viral SARS-CoV-2 polyprotein at three sites. In addition, it modulates host immune response...
Published: 7/26/2024   |   Inventor(s): Jun Wang, Chunlong Ma, Naoya Kitamura, Yanmei Hu
Keywords(s):  
Category(s): Technology Classifications > Healthcare Portfolios > Infectious Diseases, Technology Classifications > Life Sciences > Small Molecules
Broad-Spectrum Antivirals Against Enterovirus D68, A71, and Coxsackievirus B3
This invention is a set of compounds which have antiviral activity against the enteroviruses D68, A71, and coxsackievirus B3. They can be used both prophylactically, to prevent infection, and therapeutically, to treat it. Background: Enteroviruses are a group of viruses that belong to the Picornaviridae family. One enterovirus, the polio virus,...
Published: 11/16/2023   |   Inventor(s): Jun Wang, Rami Musharrafieh, Chunlong Ma, Jiantao Zhang, Yanmei Hu
Keywords(s):  
Category(s): Technology Classifications > Healthcare Portfolios, Technology Classifications > Healthcare Portfolios > Infectious Diseases, Technology Classifications > Life Sciences > Therapeutics